Skip to main content

Table 2 Univariate and multivariate analysis of baseline characteristics with HCC development

From: Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study

 

univariant analysis

p-value

multivariant analysis

p-value

 

HR (95% CI)

 

HR (95% CI)

 

Age

1.00 (0.99–1.01)

NS

  

Gender:male/female

3.11 (0.99-9.72)

NS

  

Child-Pugh score: A/B

0.48 (0.21-1.10)

NS

  

ADV-containing/Non-ADV-treatment

0.18 (0.09-0.43)

<0.05

0.18 (0.07-0.45)

<0.05

Total bilirubin: < 24/≥ 24 (μmol/L)

0.52 (0.19-1.41)

NS

  

HBV DNA: <4/≥4 (log copies/ mL)

0.85 (0.41-1.76)

NS

  

HBeAg: Positive/negative

1.16 (0.54-2.50)

NS

  
  1. HBeAg hepatitis B e antigen